Author:
Mubthasima P. P.,Singh Sridevi Annapurna,Kannan Anbarasu
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Fowler JR, Maani EV, Dunton CJ, Gasalberti DP, Jack BW (2024) Cervical cancer. StatPearls
2. Burmeister CA, Khan SF, Schäfer G, Mbatani N, Adams T, Moodley J, Prince S (2022) Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res 13:200238
3. Zhao X, Liu J, Jin D et al (2022) EphA2 promotes the development of cervical cancer through the CXCL11/PD-L1 pathway. J Oncol 2022:1–17
4. Veiga RN, De Azevedo ALK, De Oliveira JC, Gradia DF (2024) Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer. J Mol Med 102:479–493
5. Van Der Bliek AM, Shen Q, Kawajiri S (2013) Mechanisms of mitochondrial fission and fusion. Cold Spring Harb Perspect Biol 5:a011072–a011072